New program applies principles of DM to transplant patients
Related Experiment Video
Updated: Aug 21, 2026

08:05
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Abstract:
One of the most common and costly complications related to transplant patients is organ rejection due to patient non-compliance. It's a huge issue because of the complicated medication regimens transplant patients must learn to deal with, and the numerous side-effects involved. For this reason, Aetna decided to offer transplant patients extra support in the form of a DM program that focuses on medication management, and early indications are the approach is having a positive effect.

